328 related articles for article (PubMed ID: 24648894)
1. Metformin in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Li Y; Liu L; Wang B; Wang J; Chen D
Biomed Rep; 2013 Jan; 1(1):57-64. PubMed ID: 24648894
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Metformin on Aminotransferase Levels, Metabolic Parameters and Body Mass Index in Nonalcoholic Fatty Liver Disease Patients: A Metaanalysis.
Hu H; Wang J; Li X; Shen L; Shi D; Meng J
Curr Pharm Des; 2021; 27(29):3235-3243. PubMed ID: 33719959
[TBL] [Abstract][Full Text] [Related]
3. The effects of metformin administration on liver enzymes and body composition in non-diabetic patients with non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis: An up-to date systematic review and meta-analysis of randomized controlled trials.
Jalali M; Rahimlou M; Mahmoodi M; Moosavian SP; Symonds ME; Jalali R; Zare M; Imanieh MH; Stasi C
Pharmacol Res; 2020 Sep; 159():104799. PubMed ID: 32278041
[TBL] [Abstract][Full Text] [Related]
4. Functional foods and dietary supplements in the management of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Wang LL; Zhang PH; Yan HH
Front Nutr; 2023; 10():1014010. PubMed ID: 36866059
[TBL] [Abstract][Full Text] [Related]
5. The benefit of metformin in the treatment of pediatric non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials.
Gkiourtzis N; Michou P; Moutafi M; Glava A; Cheirakis K; Christakopoulos A; Vouksinou E; Fotoulaki M
Eur J Pediatr; 2023 Nov; 182(11):4795-4806. PubMed ID: 37639015
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of semaglutide in non-alcoholic fatty liver disease.
Zhu K; Kakkar R; Chahal D; Yoshida EM; Hussaini T
World J Gastroenterol; 2023 Oct; 29(37):5327-5338. PubMed ID: 37899788
[TBL] [Abstract][Full Text] [Related]
7. Effects of metformin, pioglitazone, and silymarin treatment on non-alcoholic Fatty liver disease: a randomized controlled pilot study.
Hajiaghamohammadi AA; Ziaee A; Oveisi S; Masroor H
Hepat Mon; 2012 Aug; 12(8):e6099. PubMed ID: 23087748
[TBL] [Abstract][Full Text] [Related]
8. The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment.
Ballestri S; Nascimbeni F; Romagnoli D; Lonardo A
Hepatol Res; 2016 Oct; 46(11):1074-1087. PubMed ID: 26785389
[TBL] [Abstract][Full Text] [Related]
9. Effect of metformin on nonalcoholic fatty liver based on meta-analysis and network pharmacology.
Huang Y; Wang X; Yan C; Li C; Zhang L; Zhang L; Liang E; Liu T; Mao J
Medicine (Baltimore); 2022 Oct; 101(43):e31437. PubMed ID: 36316840
[TBL] [Abstract][Full Text] [Related]
10. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G
Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473
[TBL] [Abstract][Full Text] [Related]
11. The effect of pioglitazone and metformin on liver function tests, insulin resistance, and liver fat content in nonalcoholic Fatty liver disease: a randomized double blinded clinical trial.
Razavizade M; Jamali R; Arj A; Matini SM; Moraveji A; Taherkhani E
Hepat Mon; 2013 May; 13(5):e9270. PubMed ID: 23930133
[TBL] [Abstract][Full Text] [Related]
12. Lifestyle changes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Fernández T; Viñuela M; Vidal C; Barrera F
PLoS One; 2022; 17(2):e0263931. PubMed ID: 35176096
[TBL] [Abstract][Full Text] [Related]
13. The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: A systematic review and meta-analysis.
Koutoukidis DA; Koshiaris C; Henry JA; Noreik M; Morris E; Manoharan I; Tudor K; Bodenham E; Dunnigan A; Jebb SA; Aveyard P
Metabolism; 2021 Feb; 115():154455. PubMed ID: 33259835
[TBL] [Abstract][Full Text] [Related]
14. The Relationship between Prebiotic Supplementation and Anthropometric and Biochemical Parameters in Patients with NAFLD-A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Stachowska E; Portincasa P; Jamioł-Milc D; Maciejewska-Markiewicz D; Skonieczna-Żydecka K
Nutrients; 2020 Nov; 12(11):. PubMed ID: 33187278
[TBL] [Abstract][Full Text] [Related]
15. Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis.
Angelico F; Burattin M; Alessandri C; Del Ben M; Lirussi F
Cochrane Database Syst Rev; 2007 Jan; (1):CD005166. PubMed ID: 17253544
[TBL] [Abstract][Full Text] [Related]
16. Systematic review and meta-analysis to determine the impact of iron depletion in dysmetabolic iron overload syndrome and non-alcoholic fatty liver disease.
Murali AR; Gupta A; Brown K
Hepatol Res; 2018 Feb; 48(3):E30-E41. PubMed ID: 28593739
[TBL] [Abstract][Full Text] [Related]
17. Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis.
Ma YY; Li L; Yu CH; Shen Z; Chen LH; Li YM
World J Gastroenterol; 2013 Oct; 19(40):6911-8. PubMed ID: 24187469
[TBL] [Abstract][Full Text] [Related]
18. The effects of carnitine supplementation on clinical characteristics of patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
Abolfathi M; Mohd-Yusof BN; Hanipah ZN; Mohd Redzwan S; Yusof LM; Khosroshahi MZ
Complement Ther Med; 2020 Jan; 48():102273. PubMed ID: 31987257
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Empagliflozin on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
Zhang Y; Liu X; Zhang H; Wang X
Front Endocrinol (Lausanne); 2022; 13():836455. PubMed ID: 35282455
[TBL] [Abstract][Full Text] [Related]
20. Meta-Analysis of Randomized Controlled Trials of Pharmacologic Agents in Non-alcoholic Steatohepatitis.
Said A; Akhter A
Ann Hepatol; 2017; 16(4):538-547. PubMed ID: 28611274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
